Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Improvement in cognitive function following a switch to ziprasidone from conventional antipsychotics, olanzapine, or risperidone in outpatients with schizophrenia.

Harvey PD, Meltzer H, Simpson GM, Potkin SG, Loebel A, Siu C, Romano SJ.

Schizophr Res. 2004 Feb 1;66(2-3):101-13.

PMID:
15061242
2.

Efficacy and tolerability of switching to ziprasidone from olanzapine, risperidone or haloperidol: an international, multicenter study.

Alptekin K, Hafez J, Brook S, Akkaya C, Tzebelikos E, Ucok A, El Tallawy H, Danaci AE, Lowe W, Karayal ON.

Int Clin Psychopharmacol. 2009 Sep;24(5):229-38. doi: 10.1097/YIC.0b013e32832c2624.

PMID:
19531959
3.

Effectiveness of switching to ziprasidone for stable but symptomatic outpatients with schizophrenia.

Weiden PJ, Simpson GM, Potkin SG, O'Sullivan RL.

J Clin Psychiatry. 2003 May;64(5):580-8.

PMID:
12755663
4.

Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.

Houthoofd SA, Morrens M, Sabbe BG.

Clin Ther. 2008 Sep;30(9):1565-89. doi: 10.1016/j.clinthera.2008.09.014. Review.

PMID:
18840365
5.

Health-related quality of life among patients treated with lurasidone: results from a switch trial in patients with schizophrenia.

Awad G, Hassan M, Loebel A, Hsu J, Pikalov A, Rajagopalan K.

BMC Psychiatry. 2014 Feb 23;14:53. doi: 10.1186/1471-244X-14-53.

7.

The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia.

Meltzer HY, McGurk SR.

Schizophr Bull. 1999;25(2):233-55. Review.

PMID:
10416729
8.

Improvement in social functioning in outpatients with schizophrenia with prominent negative symptoms treated with olanzapine or risperidone in a 1 year randomized, open-label trial.

Ciudad A, Olivares JM, Bousoño M, Gómez JC, Alvarez E.

Prog Neuropsychopharmacol Biol Psychiatry. 2006 Dec 30;30(8):1515-22. Epub 2006 Jul 3.

PMID:
16820255
9.

The relationship between symptomatic remission and neuropsychological improvement in schizophrenia patients switched to treatment with ziprasidone.

Buckley PF, Harvey PD, Bowie CR, Loebel A.

Schizophr Res. 2007 Aug;94(1-3):99-106. Epub 2007 May 11.

PMID:
17499480
10.

Effects of olanzapine and other antipsychotics on cognitive function in chronic schizophrenia: a longitudinal study.

Cuesta MJ, Peralta V, Zarzuela A.

Schizophr Res. 2001 Mar 1;48(1):17-28. Review.

PMID:
11278151
11.

One-year double-blind study of the neurocognitive efficacy of olanzapine, risperidone, and haloperidol in schizophrenia.

Keefe RS, Young CA, Rock SL, Purdon SE, Gold JM, Breier A; HGGN Study Group.

Schizophr Res. 2006 Jan 1;81(1):1-15. Epub 2005 Oct 3.

PMID:
16202565
12.
13.

Assessment of clinical and metabolic status, and subjective well-being, in schizophrenic patients switched from typical and atypical antipsychotics to ziprasidone.

Rossi A, Vita A, Tiradritti P, Romeo F.

Int Clin Psychopharmacol. 2008 Jul;23(4):216-22. doi: 10.1097/YIC.0b013e3282f94905.

PMID:
18545060
14.

Comparative effects of risperidone and olanzapine on cognition in elderly patients with schizophrenia or schizoaffective disorder.

Harvey PD, Napolitano JA, Mao L, Gharabawi G.

Int J Geriatr Psychiatry. 2003 Sep;18(9):820-9.

PMID:
12949850
15.

Neurocognitive effectiveness of haloperidol, risperidone, and olanzapine in first-episode psychosis: a randomized, controlled 1-year follow-up comparison.

Crespo-Facorro B, Rodríguez-Sánchez JM, Pérez-Iglesias R, Mata I, Ayesa R, Ramirez-Bonilla M, Martínez-Garcia O, Vázquez-Barquero JL.

J Clin Psychiatry. 2009 Apr 21;70(5):717-29. doi: 10.4088/JCP.08m04634.

PMID:
19389335
16.

Improvement in prosocial functioning after a switch to ziprasidone treatment.

Loebel A, Siu C, Romano S.

CNS Spectr. 2004 May;9(5):357-64.

PMID:
15115948
17.

Effect on lipid profiles of switching from olanzapine to another second-generation antipsychotic agent in veterans with schizophrenia.

Garman PM, Ried LD, Bengtson MA, Hsu C, McConkey JR.

J Am Pharm Assoc (2003). 2007 May-Jun;47(3):373-8.

PMID:
17510032
19.

Ziprasidone and cognition: the evolving story.

Harvey PD.

J Clin Psychiatry. 2003;64 Suppl 19:33-9.

20.

Long-term improvement in efficacy and safety after switching to ziprasidone in stable outpatients with schizophrenia.

Simpson GM, O'Gorman CJ, Loebel A, Yang R.

CNS Spectr. 2008 Oct;13(10):898-905.

PMID:
18955945

Supplemental Content

Support Center